Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-19 · accession 0002037144-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-19 | GPCR | Coll Crespo Blas | Chief MEDICAL Off | A - Grant | $0.00 | +75.9K | 280.9K | +37% | $0 |
| D | 2026-03-23 | 2026-03-19 | GPCR | Coll Crespo Blas | Chief MEDICAL Off | A - Grant | $0.00 | +94.0K | 94.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-19 | A | A | 75,897 | $0.00 | 280,878 | D | — | — | (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2026-03-19 | A | A | 93,984 | $0.00 | 93,984 | D | $16.82 · — to 2036-03-18 | 93,984 Ordinary Shares | (F3) The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. (F4) 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. |